While the political views of Vermont Sen. Bernie Sanders (I) and President-elect Donald Trump fall on opposite sides of the spectrum, the two men found common ground on one topic: high drug costs.
Supply Chain
Richard Gonzalez, the CEO of AbbVie, said the company will not raise drug prices past the single digits in 2017, reports Reuters.
The National Cancer Institute is creating an ambitious new program that will enable scientists to access new drugs and compounds faster for medical research, according to STAT.
The release of abuse-deterrent OxyContin directly coincides with the surging rates of heroin overdose deaths, according to a new working paper from researchers at the RAND Corp. and the Wharton School.
Beginning in February, New Brunswick, N.J.-based Johnson & Johnson will divulge price increases for its prescription drugs, reports The Washington Post.
Advertisement
Charlotte, N.C.-based SonaCare Medical earned clearance from the Food and Drug Administration for a new version of its Sonablate device.
The Food and Drug Administration granted market clearance for ResMed's AirMini device.
When a hospital acquires a physician practice, it is easy for supply chain operations to get lost in the shuffle when it comes to data transfer. Physicians' EMR and other data are often the first to transfer over, while the…
Here are six noteworthy drugs the Food and Drug Administration approved in 2016.
President-elect Donald Trump described the drug industry as "disastrous" and criticized current industry practices during a press conference on Wednesday.